MGC Pharmaceuticals
Follow
Follow Organisations, People and Lists
Stay on top of the latest updates for your desired data.
Industry Lists
Public Companies - Industrial
MGC Pharmaceuticals (ASX: MXC) is EU based specialist medical and cosmetic cannabis company with many years of technical and commercial experience in the medical cannabis industry. The Company’s founders were key figures in the Israeli medical cannabis industry and the core business strategy is to develop and supply high quality non-psychoactive Cannabinoid resin extract (“CBD”) to the growing European cosmetics and medical markets.
The Company listed on the ASX in December 2015, following a reverse takeover of Erin Resources.
The Company listed on the ASX in December 2015, following a reverse takeover of Erin Resources.
Contact Details
1202 Hay Street, WEST PERTH WA 6005
08 6382 3390
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Public Companies - Industrial list sponsored by
Collapse All Lists and Charts
Article Timeline
Company Activity
| ECM DEAL: New deal has been added | 14 Jul 2020 |
| M&A DEAL: New deal has been added | 13 Jul 2020 |
| REMUNERATION UPDATE: Brett Mitchell, Co-Founder, Executive Chair | 30 Jun 2020 |
| REMUNERATION UPDATE: Nativ Segev, Co-Founder, Executive Director & Head of Business Strategy (since May 2018); (MD 2016-2018) | 30 Jun 2020 |
| REMUNERATION UPDATE: Roby Zomer, Co-Founder, CEO, MD (since May 2018); (Chief Technical Officer 2015-2017) | 30 Jun 2020 |
| REMUNERATION UPDATE: Ross Walker, Non-Executive Director, Head of Advisory Board | 30 Jun 2020 |
| REMUNERATION UPDATE: Nick Castleden, Non-Executive Director | 30 Jun 2020 |
